Rob Toews
Partner at Radical Ventures
San Francisco Bay Area
Overview
Work Experience
Partner
2021 - Current
Radical Ventures is the world’s leading AI-focused venture capital firm. We are currently investing out of a $550m early-stage fund and an $800m growth fund. I lead the firm's Bay Area office. Investments: Datology (board observer), Delphina (board observer), Hebbia, Laredo Labs (board director), Muon Space (board director), Nabla Bio (board director), Reka (board director), Twelve Labs (board director), Unlearn (board observer)
AI Columnist
2019
I write a column for Forbes about the big picture of artificial intelligence: https://www.forbes.com/sites/robtoews/
Forbes Magazine is a business magazine that is focused on business news and financial information.
Raised $200,000,000.00 from Binance.
Investor & Board Member
2021
Twelve Labs makes video foundation models accessible via APIs to empower businesses and developers to build intelligent video products.
Raised $77,120,000.00 from Korea Investment Partners, New Enterprise Associates, WndrCo, NVentures, Radical Ventures and Index Ventures.
Founding Investor & Board Member
2022
Investor & Board Observer
2023
Investor & Board Member
2022
Muon Space designs, builds, and operates orbit satellite constellations to deliver mission-critical data.
Raised $91,703,744.00 from Congruent Ventures, ACME Capital, Costanoa Ventures, Activate Capital Partners and Radical Ventures.
Investor
2022
Hebbia is an AI platform that helps companies transform heaps of information into insights.
Raised $161,100,000.00 from Peter Thiel, Index Ventures, Andreessen Horowitz, Google Ventures and Sahin Boydas.
Investor & Board Observer
2022
Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.
Raised $134,850,000.00 from Wittington Ventures, Radical Ventures, DCVC Bio, DCVC, 8VC, Insight Partners, EPIC Ventures, Mubadala Capital, Necessary Ventures and Altimeter Capital.
Investor & Board Member
2024
Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.
Raised $37,381,000.00 from Fifty Years, Khosla Ventures, Zetta Venture Partners, Radical Ventures, Y Combinator, Boom Capital Ventures and Cantos.
Investor & Board Observer
2023
Delphina is an AI Data Scientist that helps data science teams drive business impact faster
Raised $7,500,000.00 from Costanoa Ventures, Radical Ventures and Fei-Fei Li.